{"id":"https://openalex.org/W7166315341","doi":"https://doi.org/10.66224/ihio.6.4.288","title":"Economic Evaluation of Molnopyravir, Paxlovid and Fluvoxamine in Treatment of COVID-19 Patients in Iran","display_name":"Economic Evaluation of Molnopyravir, Paxlovid and Fluvoxamine in Treatment of COVID-19 Patients in Iran","alternate_titles":[],"publication_year":2024,"publication_date":"2024-03-01","ids":{"openalex":"https://openalex.org/W7166315341","doi":"https://doi.org/10.66224/ihio.6.4.288"},"language":"fa","primary_location":{"id":"doi:10.66224/ihio.6.4.288","doi":"https://doi.org/10.66224/ihio.6.4.288","is_oa":true,"landing_page_url":"https://doi.org/10.66224/ihio.6.4.288","pdf_url":"http://journal.ihio.gov.ir/files/site1/user_files_5aeb35/pedram-A-10-475-1-6402a18.pdf","source":{"id":"https://openalex.org/S7407059072","display_name":"Iranian Journal of Health Insurance","issn_l":"2645-4297","issn":["2645-4297","2645-8225"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian Journal of Health Insurance","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7166315341"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://journal.ihio.gov.ir/files/site1/user_files_5aeb35/pedram-A-10-475-1-6402a18.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039636613","display_name":"Pedram Nourizadeh Tehrani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Pedram Nourizadeh Tehrani","raw_affiliation_strings":["Department of Health Management, Policy and Economics , School of Public Health , Tehran University of Medical Sciences , Tehran , Iran"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Management, Policy and Economics , School of Public Health , Tehran University of Medical Sciences , Tehran , Iran","institution_ids":["https://openalex.org/I70640408"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061021961","display_name":"Mobarakeh Alipanah Dolatabad","orcid":"https://orcid.org/0000-0002-3710-5821","observed_orcids":["https://orcid.org/0000-0002-3710-5821"]},"institutions":[{"id":"https://openalex.org/I161106909","display_name":"Iran University of Medical Sciences","ror":"https://ror.org/03w04rv71","country_code":"IR","type":"education","lineage":["https://openalex.org/I161106909"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Mobarakeh Alipanah Dolatabad","raw_affiliation_strings":["Department of Health Services Management, School of Management and Health Informatics, Iran University of Medical Sciences, Tehran, Iran"],"raw_orcid":"https://orcid.org/0000-0002-3710-5821","affiliations":[{"raw_affiliation_string":"Department of Health Services Management, School of Management and Health Informatics, Iran University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I161106909"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090879714","display_name":"Rajabali Daroudi","orcid":"https://orcid.org/0000-0002-0487-4114","observed_orcids":["https://orcid.org/0000-0002-0487-4114"]},"institutions":[{"id":"https://openalex.org/I70640408","display_name":"Tehran University of Medical Sciences","ror":"https://ror.org/01c4pz451","country_code":"IR","type":"education","lineage":["https://openalex.org/I70640408"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Rajabali Daroudi","raw_affiliation_strings":["Department of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"],"raw_orcid":"https://orcid.org/0000-0002-0487-4114","affiliations":[{"raw_affiliation_string":"Department of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran","institution_ids":["https://openalex.org/I70640408"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"4","first_page":"288","last_page":"299"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8379999995231628},{"id":"https://openalex.org/keywords/molnupiravir","display_name":"molnupiravir","score":0.9760000109672546},{"id":"https://openalex.org/keywords/nirmatrelvir-ritonavir","display_name":"nirmatrelvir/ritonavir","score":0.9290000200271606},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mild-to-moderate-covid-19","display_name":"mild to moderate COVID-19","score":0.8960000276565552},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9179999828338623},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.7329999804496765},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.6470000147819519},{"id":"https://openalex.org/keywords/decision-tree","display_name":"decision tree","score":0.7480000257492065},{"id":"https://openalex.org/keywords/iran","display_name":"Iran","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.756600022315979},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.7196999788284302},{"id":"https://openalex.org/C2776125615","wikidata":"https://www.wikidata.org/wiki/Q18391886","display_name":"Economic evaluation","level":2,"score":0.6563000082969666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4034000039100647},{"id":"https://openalex.org/C2985697011","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economic analysis","level":2,"score":0.32100000977516174},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.274399995803833},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26350000500679016},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.2619999945163727},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2567000091075897},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.23919999599456787}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.66224/ihio.6.4.288","doi":"https://doi.org/10.66224/ihio.6.4.288","is_oa":true,"landing_page_url":"https://doi.org/10.66224/ihio.6.4.288","pdf_url":"http://journal.ihio.gov.ir/files/site1/user_files_5aeb35/pedram-A-10-475-1-6402a18.pdf","source":{"id":"https://openalex.org/S7407059072","display_name":"Iranian Journal of Health Insurance","issn_l":"2645-4297","issn":["2645-4297","2645-8225"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian Journal of Health Insurance","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.66224/ihio.6.4.288","doi":"https://doi.org/10.66224/ihio.6.4.288","is_oa":true,"landing_page_url":"https://doi.org/10.66224/ihio.6.4.288","pdf_url":"http://journal.ihio.gov.ir/files/site1/user_files_5aeb35/pedram-A-10-475-1-6402a18.pdf","source":{"id":"https://openalex.org/S7407059072","display_name":"Iranian Journal of Health Insurance","issn_l":"2645-4297","issn":["2645-4297","2645-8225"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Iranian Journal of Health Insurance","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166315341.pdf","grobid_xml":"https://content.openalex.org/works/W7166315341.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W3002108456","https://openalex.org/W3003668884","https://openalex.org/W3010466793","https://openalex.org/W3113734454","https://openalex.org/W3133362415","https://openalex.org/W3209596279","https://openalex.org/W4200473506","https://openalex.org/W4210736465","https://openalex.org/W4281988270","https://openalex.org/W4283771385","https://openalex.org/W4295758341"],"related_works":["https://openalex.org/W4405751993","https://openalex.org/W4411152867","https://openalex.org/W4381948474","https://openalex.org/W4381252527","https://openalex.org/W4311035584","https://openalex.org/W4309163733","https://openalex.org/W4409789632","https://openalex.org/W2131311076","https://openalex.org/W4407898415"],"abstract_inverted_index":{"Economic":[0],"Evaluation":[1],"of":[2,9,19,32,42,50,55,75,79,85,105,147,164,173,176,196,203,228,244],"Molnopyravir,":[3],"Paxlovid":[4,148],"and":[5,29,39,89,107,121,139,155,198],"Fluvoxamine":[6],"in":[7,12,27,53,62,110,200,206],"Treatment":[8],"COVID-19":[10,61,204],"Patients":[11],"IranIntroduction:":[13],"Various":[14],"medications":[15],"for":[16,217],"the":[17,33,48,73,77,128,156,171,174,194,201,207,226,231,237],"treatment":[18,54,108,117,177,202],"coronavirus":[20],"disease":[21,218],"2019":[22],"(COVID-19)":[23],"have":[24],"been":[25],"introduced":[26],"outpatient":[28],"inpatient":[30],"wards.Three":[31],"referees":[34],"are":[35,213],"Nirmatrelvir/ritonavir":[36],"(Paxlovid),":[37],"Molnupiravir":[38],"Fluvoxamine.The":[40],"aim":[41,74],"this":[43,184],"study":[44,66,71,97],"was":[45,67,92,149,169],"to":[46,59,94,127,209],"investigate":[47,95],"cost-effectiveness":[49,78,162],"these":[51],"drugs":[52],"patients":[56,205],"with":[57,72,167,178],"mild":[58,208],"moderate":[60,210],"Iran.Methods:":[63],"The":[64],"present":[65],"an":[68],"economic":[69],"evaluation":[70],"investigating":[76],"drugs.A":[80],"two-part":[81],"decision":[82,86],"analysis":[83],"model":[84,88,91],"tree":[87],"Markov":[90],"used":[93],"costeffectiveness.The":[96],"parameters":[98],"included":[99],"hospitalization,":[100],"death":[101],"rate,":[102],"drugs,":[103],"quality":[104],"life":[106],"costs":[109],"2022.":[111],"Results:The":[112],"results":[113],"showed":[114],"that":[115,193],"standard":[116],"had":[118,131],"higher":[119,133,150],"cost":[120,135,146,172],"lower":[122,140],"average":[123,129,134,145,157],"outcome":[124],"(QALY)":[125],"compared":[126,166],"fluvoxamine.Molnopyravir":[130],"a":[132,242],"(202.205.422":[136],"vs.":[137,143,153,160],"155.243.881)":[138],"QALY":[141,158],"(4.352":[142],"4.363).The":[144],"(133,712,604":[151],"Rials":[152],"3,328,029)":[154],"(0.969":[159],"0.966).The":[161],"ratio":[163],"pexelloids":[165,179],"fluvoxamine":[168],"302.781.040.50Rials.If":[170],"course":[175],"is":[180,220,233,241],"less":[181],"than":[182],"2.108.425Rials,":[183],"drug":[185,232],"will":[186],"be":[187,191],"cost-effective.":[188],"Conclusion:It":[189],"can":[190],"concluded":[192],"use":[195],"paxlovid":[197],"molnopyravir":[199],"stage":[211],"who":[212],"at":[214,223],"high":[215],"risk":[216],"progression":[219],"not":[221],"cost-effective":[222,234],"current":[224],"prices.In":[225],"case":[227],"fluvoxamine,":[229],"although":[230],"based":[235],"on":[236],"available":[238],"evidence,":[239],"there":[240],"lot":[243],"uncertainty":[245],"about":[246],"its":[247],"effectiveness.":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7166315341","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2026-06-28T00:00:00"}
